Literature DB >> 30377720

Left Hepatectomy with Combined Resection and Reconstruction of Right Hepatic Artery for Bismuth Type I and II Perihilar Cholangiocarcinoma.

Teiichi Sugiura1, Yukiyasu Okamura2, Takaaki Ito2, Yusuke Yamamoto2, Ryo Ashida2, Katsuhisa Ohgi2, Masahiro Nakagawa3, Katsuhiko Uesaka2.   

Abstract

BACKGROUND: Right hepatectomy with caudate lobectomy (RHx) is considered an appropriate procedure for Bismuth type I/II perihilar cholangiocarcinoma in terms of its anatomical and oncological aspect. However, validity of left hepatectomy with caudate lobectomy (LHx) concomitant with arterial resection and reconstruction (AR) is not fully evaluated.
METHODS: The patients who underwent surgical resection for Bismuth type I/II perihilar cholangiocarcinoma between 2002 and 2013 were studied. The standard procedure for Bismuth type I/II cholangiocarcinoma in the institute was RHx, while in patients who had insufficient functional reserve of the left liver, LHx was selected, irrespective of the necessity of AR. The clinicopathologic and perioperative outcomes after LHx + AR were compared with those after RHx.
RESULTS: The surgical procedures comprised LHx + AR in 12 and RHx in 24. The left liver volume and left liver functional reserve were significantly lower with LHx + AR than with RHx (left liver volume: 28.0 vs. 33.7%, p = 0.026; estimated indocyanine green clearance of the left liver: 0.036 vs. 0.046, p < 0.001). The rate of surgical morbidity was almost identical between the two procedures. No arterial reconstruction-related complications occurred. The overall 3- and 5-year survival rates and median survival time were 66.7%, 41.7% and 44 months for LHx + AR and 70.8%, 49.0% and 57 months for RHx (p = 0.640).
CONCLUSION: LHx + AR for Bismuth type I/II perihilar cholangiocarcinoma is considered to be a valid alternative to RHx in patients with an insufficient left liver functional reserve.

Entities:  

Mesh:

Year:  2019        PMID: 30377720     DOI: 10.1007/s00268-018-4833-1

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  9 in total

1.  Prognostic Impact of Paraaortic Lymph Node Metastasis in Extrahepatic Cholangiocarcinoma.

Authors:  Nobuhito Nitta; Katsuhisa Ohgi; Teiichi Sugiura; Yukiyasu Okamura; Takaaki Ito; Yusuke Yamamoto; Ryo Ashida; Shimpei Otsuka; Keiko Sasaki; Katsuhiko Uesaka
Journal:  World J Surg       Date:  2020-10-20       Impact factor: 3.352

2.  Validation study of postoperative liver failure and mortality risk scores after liver resection for perihilar cholangiocarcinoma.

Authors:  Takehiro Noji; Satoko Uemura; Jimme K Wiggers; Kimitaka Tanaka; Yoshitsugu Nakanishi; Toshimichi Asano; Toru Nakamura; Takahiro Tsuchikawa; Keisuke Okamura; Pim B Olthof; William R Jarnagin; Thomas M van Gulik; Satoshi Hirano
Journal:  Hepatobiliary Surg Nutr       Date:  2022-06       Impact factor: 8.265

Review 3.  Concomitant Hepatic Artery Resection for Advanced Perihilar Cholangiocarcinoma: A Narrative Review.

Authors:  Takehiro Noji; Satoshi Hirano; Kimitaka Tanaka; Aya Matsui; Yoshitsugu Nakanishi; Toshimichi Asano; Toru Nakamura; Takahiro Tsuchikawa
Journal:  Cancers (Basel)       Date:  2022-05-27       Impact factor: 6.575

4.  Effect of hepatic artery resection and reconstruction on the prognosis of patients with advanced hilar cholangiocarcinoma.

Authors:  Yuan-Ming Li; Zhi-Xin Bie; Run-Qi Guo; Bin Li; Cheng-En Wang; Fei Yan
Journal:  World J Gastrointest Oncol       Date:  2022-04-15

5.  Utility of remnant liver volume for predicting posthepatectomy liver failure after hepatectomy with extrahepatic bile duct resection.

Authors:  R Yamamoto; T Sugiura; Y Okamura; T Ito; Y Yamamoto; R Ashida; K Ohgi; S Otsuka; K Uesaka
Journal:  BJS Open       Date:  2021-01-08

6.  Left-side vs. right-side hepatectomy for hilar cholangiocarcinoma: a meta-analysis.

Authors:  Wenxuan Wu; Qiyang Cheng; Junru Chen; Diyu Chen; Xiaode Feng; Jian Wu
Journal:  World J Surg Oncol       Date:  2021-04-10       Impact factor: 2.754

7.  Prognostic Value of Carbohydrate Antigen 19-9 and the Surgical Margin in Extrahepatic Cholangiocarcinoma.

Authors:  Ryusei Yamamoto; Teiichi Sugiura; Ryo Ashida; Katsuhisa Ohgi; Mihoko Yamada; Shimpei Otsuka; Katsuhiko Uesaka
Journal:  Ann Gastroenterol Surg       Date:  2021-11-09

8.  Preoperative risk factors for early recurrence after resection of perihilar cholangiocarcinoma.

Authors:  Ryusei Yamamoto; Teiichi Sugiura; Ryo Ashida; Katsuhisa Ohgi; Mihoko Yamada; Shimpei Otsuka; Takeshi Aramaki; Koiku Asakura; Katsuhiko Uesaka
Journal:  BJS Open       Date:  2022-09-02

9.  Major hepatectomy with combined vascular resection for perihilar cholangiocarcinoma.

Authors:  T Sugiura; K Uesaka; Y Okamura; T Ito; Y Yamamoto; R Ashida; K Ohgi; S Otsuka; M Nakagawa; T Aramaki; K Asakura
Journal:  BJS Open       Date:  2021-07-06
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.